 ÏÊ»¨( 219)  ¼¦µ°( 0)
|
: Z/ o1 |! n+ R% ^6 _' P6 v. c6 v7 a" E4 v9 W! g6 `, z
! Q, S( ?0 m+ ?% J& L, e
´ó¼ÒºÃ£¬
$ M4 M" U3 ^7 G5 y* A$ B; f7 w1 Z8 w: G4 ~: w1 Z
»¶Ó¹âÁÙ½¡¿µÓªÑøÕ¾É̳ǡ£ÎÒÊǽ¡¿µÓªÑøÕ¾µÄ°æÖ÷¡£ÎÒ±ÏÒµÓÚU Of A ÓªÑøÏµ¡£Ä¿Ç°¾ÓªÓªÑø²úÆ·¡£ÎÒËù¾ÓªµÄÓªÑø²úÆ·±£Öʱ£Á¿¡£¶øÇÒÔÚͬÑùµÄÆ·ÅÆÀÎÒ±£Ö¤¼ÛÇ®×îµÍ¡£ ¿µ¼ÓÃÀ²úÆ·ÊÇÎÒĿǰ¾ÓªµÄÖ÷Òª²úÆ·Ö®Ò»¡£ÎªÁËÄúµÄ·½±ã£¬ËùÓвúÆ·µÄÏêϸÇé¿öºÍ¼ÛÇ®¿ÉÒÔµã»÷ÕâÀïÕÒµ½
6 o7 @1 E, D. w% t) {4 Z[url]http://www.edmontonchina.ca/forumdisplay.php?fid=91
9 w0 x3 j% S1 T, `/ F, c7 O- u3 {5 c6 K: z
¶©¹º×Éѯ£º£¨780£©669-6586²úÆ·  780-249-13657 `% I @9 u8 l1 Z4 ]
Email£º c.health@hotmail.com; `7 K1 Z# b* t
7 t% P; h0 q( r8 u4 R* p2 G9 p¿µ¼ÓÃÀ²úÆ·¼ò½é£º' k, d) F. C" W
& z9 t. o U8 o3 q¼ÓÃÀ¿ÆÑÐÖÆÒ©ÓÐÏÞ¹«Ë¾Î»ì¶×ÔÈ»×ÊÔ´·á¸»µÄ¼ÓÄô󰲴óÂÔÊ¡£¬Ç±ÐÄÑÐÖÆÌìȻҩÁƽ¡¿µ®bÆ·¡£ÎÒÃǵÄ×î´óÐÄÔ¸Êǽ«ÓÅÖÊÌìȻֲÎï»òº£ÑóÉúÎᆱ»ª£¬½áºÏ×ÔÈ»Éú»îµÄ½¡¿µÀíÄîÍÆ½é¸øËùÓмÒÍ¥£¬ ÁîÄãºÍ¼ÒÈËÊܵ½´¿×ÔÈ»µÄ±£»¤£¬×à³öÇáËɽ¡¿µÔÏÀÖ¡£ V. }( Z5 @/ @
/ m- K ~6 g9 \
¼ÓÃÀ¿ÆÑÐÖÆÒ©ÊǼÓÄôó±¾ÍÁ¾ß¹æÄ£ºÍʵÁ¦µÄÖÆÒ©¹«Ë¾¡£ÎÒÃǵÄÖ÷ÒªÒµÎñ°üÀ¨ÓÅÖʱ£½¡Æ·µÄÉú®b¡¢ÁãÊÛ¡¢Åú·¢£¬¸ü ‘´Óʸ߼¶±£½¡Æ·Éú®bµÄ³§¼ÒºÍ¸öÈËÌṩ¿É¿¿ÖÜÈ«µÄ¼Ó¹¤·þÎñ (OEM)¡£×Ô³ÉÁ¢ÒÁʼ£¬¼ÓÃÀ¿ÆÑÐ ²»¶ÏͶ·Å´óÁ¿×ÊÔ´Ñо¿ÌìÈ»½¡¿µÆ·¡£Ê®¶àÄêǰÒѳɹ¦½«ÌìÈ»º£±ªÓÍ¡¢ÉÈýÎÄÓãÓÍÔÓÍת»¯Îª¶àÖÖ±£½¡¹¦Ð§£¬ÈÝÒ×ÎüÊյĽ¡¿µ®bÆ·¡£ÆäUNCLE BILL Æ·ÅÆµÄÌìÈ»º£±ªÓÍ£¬ÉÓãÓÍ£¬ÂÑÁ×Ö¬µÈÌìÈ»®bÆ·Ê®¶àÄêÀ´Ò»Ö±±¸ÊÜÏû·ÑÕßÐÅÀµ£¬ÊÇ´ó¼Ò×ÔÓúÍÀ¡ÔùÇ×ÓѵÄÊ×Ñ¡ºÍÖ¸¶¨®bÆ·¡£- H8 w( {! }& \, S# C# d* m% J
7 ^ V2 {0 N1 ^; A S3 t) m% |& W
¶þÊ®ÔØ ¾Óª£¬ ¶þÊ®ÔØ³ÏÐÅ£¬ Ò»Èç¼ÈÍù. ¸ß¿Æ¼¼Í¶ÈëºÍ³¤¾QͶ×ʳɾÍÁ˼ÓÃÀ¿ÆÑÐÖÆÒ© ÔÚ½¡¿µ®bÆ·Òµ½çµÄÇ̳þµØÎ»£¬ÊµÁ¦²»ÈÝÖÃÒÉ¡£Ê±ÖÁ½ñÈÕ, ¼ÓÃÀ¿ÆÑÐÒÑ·¢Õ¹ ‘Ò»¼äÓÐʵÁ¦ºÍ¹æÄ£µÄÖÆÒ©¹«Ë¾¡£¼ÓÃÀµÄ¼¼ÊõÍÅÒ²ÈÕÒæ×³´ó£¬³ýÍøÂÞ±¾µØÒ½Ò©Ïµ¾«Ó¢Í⣬¸üÖØ½ðͶ×ÊÉ豸¾«Á¼µÄÒ©Æ·¼ìÑéʵÑéÊÒ£¬ ¶ÔÿÅú®bÆ·½øÐÐ Standard Operation Procedure (SOP)¼ì²â£¬½¨Á¢ÖÊÁ¿×·×Ù»ØÊÕϵͳ£¬ ¾ø¶Ô·ûºÏ¼ÓÄôóÎÀÉú²¿Ò©Îï¼à¹ÜÒªÇó, Æ·ÖÊ ‘Òµ½çÖ®¹Ú¡£ ! G1 d0 m8 Z" o' p
: e' ^- P% m4 {9 F- f# Y¼ÓÃÀ¿ÆÑÐÖÆÒ©´´Á¢ºÇ»¤ÉíÐĵġ°¿µ¼ÓÃÀ¡±£¬¡°±êÊ塱һϵÁб£½¡¾«Æ·£¬ ÁÆÐ§ÏÔÖø£¬ÉîÊÜÓüÒÐÅÀµ¡£¼ÓÃÀ¿ÆÑÐÊôÏÂËùÓЮbÆ·¾ùÒÑÉ걨¼ÓÄôóÎÀÉú²¿£¬ÊÇ×îÖµµÃÐÅÀµµÄÌìÈ»±£½¡Æ·Éú®b³§¼Ò¡¢ÖøÃû½¡¿µ®bÆ·¶À¼Ò´úÀíºÍÅú·¢ÉÌ¡£ - r0 C- E) H( g% @1 u! I
0 M% a6 n0 Q" f¼ÓÃÀ¿ÆÑÐÉèÓжàÌõÏȽøµÄÉú®bÏߣ¬´ÓÖÆÔìµ½°ü×°¸÷ÖÖÉú®b³ÌÐò£¬¾ùÓɵçÄÔ¿ØÖÆ£¬²¢ÓµÓÐÉ豸ÍêÉÆµÄʵÑéÊÒ£¬¶ÔËùÓвÄÖʼ°ÖÆ³ÉÆ·½øÐÐÑϸñ²âÊÔ£¬·¢»Ó¿ÆÑ§¹ÜÀíµÄ³¬×¿Ð§ÄÜ¡£¼ÓÃÀµÄרҵÍŶӼá³ÖÒÔÆ·ÖÊΪ±¾£¬Á¦ÕéÍêÃÀ£¬²»¶ÏÇó½øºÍ´´Ð¡£ + W2 S0 [- @2 W: j4 o% b5 T' S
# {3 L7 }. M+ p* [# Y: N: J
¼ÓÃÀ¿ÆÑÐÓµÓÐÉ豸ÍêÉÆµÄʵÑéÊÒ£¬ ÎÒÃǵÄרҵ¼¼ÊõÔ±¶Ô¸÷ÖÖÔÁϺÍÖÆ³ÉÆ·½øÐзÖÎö£¬ È·±£ÔÁϸßЧÐÔ£¬²¢Ñϸñ²âÊÔÿÅú²úÆ·µÄÖÊÁ¿ºÍ°²È«ÐÔ¡£¼ÓÃÀ¿ÆÑÐÖÆÒ©Ëù²ÉÓÃÔ²ÄÁÏ£¬ ÖÆÔì¹ý³ÌºÍ³ÉÖÊÁ¿¾ù·ûºÏ«ÃÀ¹úÒ©µä» * (US Pharmacopoeia (USP))±ê×¼£¬²¿·ÖÔÁϺͮbÆ·ÉõÖÁ³¬¹ý´Ë±ê×¼¡£ $ B+ |% ]- x( l2 ]( C
/ @& e9 P' y! L/ ^
¼ÓÃÀ¿ÆÑÐÖÆÒ©µÄרҵ¾«Ó¢ÓÐÀ´×Ô±±ÃÀÖøÃû´óѧҽҩϵµÄ˶ʿºÍ ²©Ê¿£¬ ¼ÈÓÐÀ´×ÔÖйúÌìȻҩÎïÓë·ÂÉúÒ©Îï¹ú¼ÒÖØµãʵÑéÊÒ£¬»¹Óб±ÃÀÖÆÒ©ÐÐÒµ¾Ñé·á¸»µÄ¼¼Ê¦¡£ËûÃǶÔÌìÈ»®bÆ·µÄ¹¦Ð§ºÍÒ©ÀíÌØÐÔÓÐÉîÇÐÁ˽⡣¼ÓÃÀ¿ÆÑÐÖÆÒ©ÒѲ¼À³¿Ë´óѧ£¬ POLECNECTARÂ̷佺¹«Ë¾µÈ½øÐпÆÑкÏ×÷£¬²»¶Ï¸ÄÁ¼Ñз¢²úÆ·£¬ÎñÇó¸øÓè¹Ë¿Í×î¼ÑÆ·ÖÊ¡£2 g6 |" _2 m! K
1 p4 a- W7 D9 [6 q" ^[ ±¾Ìû×îºóÓÉ ½¡¿µÓªÑøÕ¾ ÓÚ 2008-11-17 12:54 ±à¼ ]9 G! P* r" y" Y2 P& h
gmp.gif (9.82 KB, ÏÂÔØ´ÎÊý: 36)7 u. x0 ^4 ~6 j- f" v& t+ Q5 t
GMO Approval
* @( C+ d% v' O# b* ~, C+ ^* I2 ^5 f. ~/ v+ y; l+ T
site_lis.gif (14.48 KB, ÏÂÔØ´ÎÊý: 16)
/ M% V. _, f% f+ y2 ]) R, sCanadian Licence
4 |. h; d( x5 E6 q- R" i9 [7 ~: Y" D
|
|